文献速递眼底病与葡萄膜炎

玻璃体腔注气玻璃体溶解术治疗玻璃体黄斑牵拉结局的回顾性研究

A RETROSPECTIVE STUDY ON THE OUTCOMES OF PNEUMATIC VITREOLYSIS FOR THE TREATMENT OF VITREOMACULAR TRACTION.
PubMed 文献 · Retina · 2025-01-01

该单中心回顾性研究分析了92例连续接受玻璃体腔注气玻璃体溶解术(PVL)的症状性玻璃体黄斑牵拉(VMT)伴或不伴黄斑裂孔(MH)患者。结果显示VMT缓解率为60%,MH患者缓解率为86%,小MH闭合率为29%;人工晶状体眼是VMT缓解的唯一预测因素(OR 0.232,P=0.013)。作者认为注射0.2 cc C2F6并配合体位对症状性局灶性VMT和(极)小MH伴VMT似乎有益且并发症有限。

要点

  • PVL后VMT缓解率60%,MH患者VMT缓解率86%,小MH闭合率29%。
  • 人工晶状体眼是VMT缓解的唯一预测因素(OR 0.232,P=0.013)。
  • 2例(2.2%)发生视网膜裂孔,其中1例导致视网膜脱离;2例VMT患者(3.17%)发生MH。

核心结论

  • 作者认为,注射0.2 cc C2F6并配合体位的PVL对症状性局灶性VMT和伴VMT的(极)小MH似乎有益且并发症有限,尤其对晶状体眼患者。
  • 本研究并发症率低于既往报告。

研究设计与样本

  • 回顾性、单中心分析,纳入2022年1月至2024年3月在鲁汶大学医院接受PVL治疗的92例连续VMT(±MH)患者。

主要发现

  • VMT缓解发生在60%的VMT患者和86%的MH患者中。
  • 小MH闭合发生在29%的小MH中。
  • 晶状体状态是VMT缓解的唯一预测因素,人工晶状体眼的比值比为0.232(P=0.013)。
  • 成功的PVL与VMT患者(P=0.007)和MH患者(P=0.034)最佳矫正视力的显著改善相关。
  • 2例患者(2.2%)发生视网膜裂孔,其中1例导致视网膜脱离;2例VMT患者(3.17%)发生MH。

关键数值与推荐

  • VMT缓解率60%,MH患者VMT缓解率86%,小MH闭合率29%。
  • 人工晶状体眼VMT缓解的OR为0.232(P=0.013)。
  • PVL后VMT患者BCVA改善P=0.007,MH患者BCVA改善P=0.034。

临床怎么用

  • 原文结论认为PVL使用0.2 cc C2F6注射并后续体位对症状性局灶性VMT和伴VMT的(极)小MH似乎有益且并发症有限,尤其对晶状体眼患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To study the effectiveness and safety of pneumatic vitreolysis (PVL) for the treatment of symptomatic vitreomacular traction (VMT) and macular holes (MHs) with VMT. METHODS: This was a retrospective, monocentric analysis of 92 consecutive VMT (±MH) patients treated with pneumatic vitreolysis at University Hospitals Leuven between January 2022 and March 2024. RESULTS: Release of VMT occurred in 60% of the patients who had VMT and in 86% of the patients who had MHs. MH closure occurred in 29% of the small MHs. Lens status was the only predictor of VMT release, with an odds ratio of 0.232 for pseudophakia ( P = 0.013). Successful pneumatic vitreolysis was associated with significant improvements in the best-corrected visual acuity in patients with VMT ( P = 0.007) and in patients with MHs ( P = 0.034). Two patients (2.2%) suffered a retinal tear, one of which led to retinal detachment. Two patients with VMT (3.17%) developed a MH. CONCLUSION: Pneumatic vitreolysis using the injection of 0.2 cc of C2F6 and subsequent posturing seems to be beneficial with limited complications for symptomatic focal VMT and for (very) small MHs with VMT, especially in phakic patients. The complication rate in this study was lower than that previously reported.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. De Clerck I, Bivort J, Van Calster J, et al. A RETROSPECTIVE STUDY ON THE OUTCOMES OF PNEUMATIC VITREOLYSIS FOR THE TREATMENT OF VITREOMACULAR TRACTION. Retina. 2025. PMID: 39486050. doi:10.1097/IAE.0000000000004319

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。